BTMDW | tickerfilter.com

Fundamental analysis

44%

Profitability 27%

Dept financing 33%

Liquidity 3%

Performance 73%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0 0%

1 Month

0 0%

3 Months

0 0%

6 Months

0 0%

1 Year

0 0%

2 Year

0 0%

Key data

Stock price

N/A

P/E Ratio

106.37

DAY RANGE

N/A - N/A

EPS

N/A

52 WEEK RANGE

N/A - N/A

52 WEEK CHANGE

N/A

MARKET CAP

335.804 M

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

N/A

AVERAGE 30 VOLUME

N/A

Company detail

CEO: Terry S. Weber
Region: US
Website: biote.com
Employees: 0
IPO year: 2021

Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Haymaker Acquisition Corp. III does not have any significant operations. The company was incorporated in 2020 and is based in New York, New York.

BTMDW - biote Corp.